🇰🇷 South Korea Country × Condition
liver cancer Clinical Trials in South Korea
Active clinical trials for liver cancer with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT06326502 Phase 1
Recruiting
A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma
Enrollment
50 pts
Country
🇰🇷 South Korea
Etnova Therapeutics Corp.
View Trial → NCT06114082 Phase 2
Recruiting
TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma
Enrollment
128 pts
Country
🇰🇷 South Korea
Seoul National University Hospital
View Trial → Frequently Asked Questions
How many liver cancer clinical trials are active in South Korea?
There are currently 2 active clinical trials for liver cancer with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a liver cancer clinical trial in South Korea?
To join a liver cancer clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are liver cancer trials in South Korea?
Active liver cancer trials in South Korea span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.